Drugs and Devices

FDA approves new multiple sclerosis drug

On March 27, the U.S. Food and Drug Administration (FDA) approved Tecfidera (dimethyl fumarate) capsules to treat adults with relapsing forms of multiple sclerosis. Read more.


Related Articles:

Leave a Reply

You have to agree to the comment policy.

 

Shares